Earnings · China A-shares
Zhejiang Wecome Pharmaceutical Co., Ltd. Class A (300878) earnings
Zhejiang Wecome Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit +81.37% year on year, +81.07% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -0.50% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- +81.37%
- Excl. one-offs YoY
- +81.07%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -1.65% | — |
| 3 days | -0.50% | — |
| 7 days | +13.62% | — |
| 14 days | +6.95% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +5.44%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | -¥23.08M | +81.37% | +81.07% | +17.86% | -0.16 | -2.57% | -0.50% | — | — |
| 2026 interim report | 2026-08-29 | -¥22.26M | +65.34% | +68.96% | +10.11% | -0.15 | -2.47% | +2.34% | -11.72% | -2.39% |
| 2026 Q1 report | 2026-04-29 | ¥1.74M | +117.69% | +131.54% | -0.16% | 0.01 | 0.19% | +10.78% | +13.72% | +12.78% |
| 2025 annual report | 2026-04-29 | -¥227.34M | -54.21% | +10.20% | -35.86% | -1.57 | -21.78% | +10.78% | +13.72% | +12.78% |
| 2025 Q3 report | 2025-10-30 | -¥123.85M | -380.87% | — | -59.20% | -0.86 | -11.40% | +15.89% | -4.60% | +0.15% |
| 2025 interim report | 2025-08-28 | -¥64.22M | -552.50% | — | -61.42% | -0.44 | -5.72% | -0.52% | +6.96% | +1.46% |
| 2025 Q1 report | 2025-04-29 | -¥9.85M | -140.50% | — | -65.10% | -0.07 | -0.86% | +4.66% | +13.99% | +11.41% |
| 2024 annual report | 2025-04-29 | -¥147.43M | -1546.42% | — | -32.41% | -1.03 | -11.75% | +4.66% | +13.99% | +11.41% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.